Analysen von Andrew Stott
17.02.23 | Air Liquide Buy | UBS AG | |
16.02.23 | Air Liquide Buy | UBS AG | |
13.02.23 | FUCHS Neutral | UBS AG | |
08.02.23 | Yara International ASA Neutral | UBS AG | |
23.01.23 | LANXESS Buy | UBS AG | |
18.01.23 | BASF Sell | UBS AG | |
16.01.23 | WACKER CHEMIE Buy | UBS AG | |
16.01.23 | LANXESS Buy | UBS AG | |
Werbung
|
|||
16.01.23 | Evonik Neutral | UBS AG | |
16.01.23 | BASF Sell | UBS AG | |
16.01.23 | FUCHS Neutral | UBS AG | |
16.01.23 | Akzo Nobel Buy | UBS AG | |
09.01.23 | Akzo Nobel Buy | UBS AG | |
09.01.23 | WACKER CHEMIE Buy | UBS AG | |
09.01.23 | LANXESS Buy | UBS AG | |
09.01.23 | BASF Sell | UBS AG | |
05.01.23 | Air Liquide Buy | UBS AG | |
13.12.22 | Givaudan Sell | UBS AG | |
13.12.22 | Air Liquide Buy | UBS AG | |
13.12.22 | Akzo Nobel Buy | UBS AG | |
13.12.22 | FUCHS Neutral | UBS AG | |
13.12.22 | Covestro Neutral | UBS AG | |
13.12.22 | Linde Buy | UBS AG | |
13.12.22 | Evonik Neutral | UBS AG | |
13.12.22 | K+S Neutral | UBS AG | |
13.12.22 | Yara International ASA Neutral | UBS AG | |
13.12.22 | BASF Sell | UBS AG | |
13.12.22 | Symrise Buy | UBS AG | |
13.12.22 | LANXESS Buy | UBS AG | |
13.12.22 | WACKER CHEMIE Buy | UBS AG | |
28.11.22 | Akzo Nobel Buy | UBS AG | |
28.11.22 | FUCHS Neutral | UBS AG | |
28.11.22 | Covestro Neutral | UBS AG | |
28.11.22 | BASF Sell | UBS AG | |
28.11.22 | WACKER CHEMIE Neutral | UBS AG | |
28.11.22 | Evonik Neutral | UBS AG | |
28.11.22 | LANXESS Buy | UBS AG | |
28.11.22 | Givaudan Sell | UBS AG | |
28.11.22 | Symrise Buy | UBS AG | |
28.11.22 | Linde Buy | UBS AG | |
28.11.22 | Air Liquide Buy | UBS AG | |
28.11.22 | K+S Neutral | UBS AG | |
21.11.22 | Symrise Buy | UBS AG | |
21.11.22 | Givaudan Sell | UBS AG | |
21.11.22 | Akzo Nobel Buy | UBS AG | |
21.11.22 | Covestro Neutral | UBS AG | |
21.11.22 | BASF Sell | UBS AG | |
17.11.22 | K+S Neutral | UBS AG | |
11.11.22 | LANXESS Buy | UBS AG | |
11.11.22 | LANXESS Buy | UBS AG |